Clinical Trials in Cleveland

Showing 1941-1960 of 16,969 trials

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

NCT06129747

The standard treatment for participants whose cancer has returned after breast conserving surgery is radiation given twice daily (separated by at least 6 hours) for a total of 30 treatments. The purpose of this study is to find out if giving radiation once a day for 15 treatments after repeat breast conserving surgery works as well as giving it the standard way.

Breast CancerTumor, Breast

Case Comprehensive Cancer Center55 participantsStarted Nov 2023

Cleveland, Ohio, United States • Cleveland, Ohio, United States

COMPLETEDPhase 1/2< 1 mile

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

NCT03375047

This Phase 1/2, first-in-human study evaluated the safety and tolerability of single and multiple escalating doses of MRT5005 administered by nebulization to the respiratory tract of adult subjects with cystic fibrosis (CF).

Cystic Fibrosis

Sanofi42 participantsStarted May 2018

Birmingham, Alabama, United States • Denver, Colorado, United States • Gainesville, Florida, United States +13 more locations

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

Find Trials by Condition in Cleveland

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

A Prospective Sub-Study of the Global Hypophosphatasia Registry

LURN: Urinary Urgency Phenotyping Protocol

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

FX Shoulder Prospective Clinical Study

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

SPEARHEAD-3 Pediatric Study

His-Bundle Corrective Pacing in Heart Failure

Global Registry for Endovascular Aortic Treatment (GREAT)

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma